S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
The perfect AI stock under $10 (Ad)
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
MILAN FASHION PHOTOS: Feben, Rave Review promote looks for women of all shapes, ages and sizes
The perfect AI stock under $10 (Ad)
Caribbean leaders meet with Haiti's prime minister. Foreign force deployment is on the agenda
What recession? Professional forecasters raise expectations for US economy in 2024
My wife was skeptical... until I showed her my account balance. (Ad)
Stock market today: Asian shares mostly decline, while Tokyo again touches a record high
AT&T will give $5 to customers hit by cellphone network outage
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
The perfect AI stock under $10 (Ad)
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
MILAN FASHION PHOTOS: Feben, Rave Review promote looks for women of all shapes, ages and sizes
The perfect AI stock under $10 (Ad)
Caribbean leaders meet with Haiti's prime minister. Foreign force deployment is on the agenda
What recession? Professional forecasters raise expectations for US economy in 2024
My wife was skeptical... until I showed her my account balance. (Ad)
Stock market today: Asian shares mostly decline, while Tokyo again touches a record high
AT&T will give $5 to customers hit by cellphone network outage
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
The perfect AI stock under $10 (Ad)
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
MILAN FASHION PHOTOS: Feben, Rave Review promote looks for women of all shapes, ages and sizes
The perfect AI stock under $10 (Ad)
Caribbean leaders meet with Haiti's prime minister. Foreign force deployment is on the agenda
What recession? Professional forecasters raise expectations for US economy in 2024
My wife was skeptical... until I showed her my account balance. (Ad)
Stock market today: Asian shares mostly decline, while Tokyo again touches a record high
AT&T will give $5 to customers hit by cellphone network outage
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
The perfect AI stock under $10 (Ad)
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
MILAN FASHION PHOTOS: Feben, Rave Review promote looks for women of all shapes, ages and sizes
The perfect AI stock under $10 (Ad)
Caribbean leaders meet with Haiti's prime minister. Foreign force deployment is on the agenda
What recession? Professional forecasters raise expectations for US economy in 2024
My wife was skeptical... until I showed her my account balance. (Ad)
Stock market today: Asian shares mostly decline, while Tokyo again touches a record high
AT&T will give $5 to customers hit by cellphone network outage

Fresh Tracks Therapeutics (FRTX) Competitors

$0.91
+0.01 (+1.11%)
(As of 02/23/2024 08:54 PM ET)

FRTX vs. CELZ, TCON, NSTG, TTNP, ALBT, GENE, FNCH, PALI, EIGR, and ELOX

Should you be buying Fresh Tracks Therapeutics stock or one of its competitors? The main competitors of Fresh Tracks Therapeutics include Creative Medical Technology (CELZ), TRACON Pharmaceuticals (TCON), NanoString Technologies (NSTG), Titan Pharmaceuticals (TTNP), Avalon GloboCare (ALBT), Genetic Technologies (GENE), Finch Therapeutics Group (FNCH), Palisade Bio (PALI), Eiger BioPharmaceuticals (EIGR), and Eloxx Pharmaceuticals (ELOX). These companies are all part of the "biological products, except diagnostic" industry.

Fresh Tracks Therapeutics vs.

Creative Medical Technology (NASDAQ:CELZ) and Fresh Tracks Therapeutics (NASDAQ:FRTX) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, earnings, valuation, profitability, community ranking, media sentiment and dividends.

Creative Medical Technology has a net margin of 0.00% compared to Creative Medical Technology's net margin of -91.29%. Fresh Tracks Therapeutics' return on equity of -69.54% beat Creative Medical Technology's return on equity.

Company Net Margins Return on Equity Return on Assets
Creative Medical TechnologyN/A -69.54% -64.36%
Fresh Tracks Therapeutics -91.29%-102.00%-81.35%

1.4% of Creative Medical Technology shares are held by institutional investors. Comparatively, 1.7% of Fresh Tracks Therapeutics shares are held by institutional investors. 3.3% of Creative Medical Technology shares are held by company insiders. Comparatively, 0.2% of Fresh Tracks Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Creative Medical Technology has a beta of 2.2, indicating that its share price is 120% more volatile than the S&P 500. Comparatively, Fresh Tracks Therapeutics has a beta of 0.4, indicating that its share price is 60% less volatile than the S&P 500.

Creative Medical Technology received 71 more outperform votes than Fresh Tracks Therapeutics when rated by MarketBeat users. Likewise, 68.93% of users gave Creative Medical Technology an outperform vote while only 0.00% of users gave Fresh Tracks Therapeutics an outperform vote.

CompanyUnderperformOutperform
Creative Medical TechnologyOutperform Votes
71
68.93%
Underperform Votes
32
31.07%
Fresh Tracks TherapeuticsOutperform Votes
No Votes
Underperform Votes
1
100.00%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Creative Medical Technology
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Fresh Tracks Therapeutics
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Creative Medical Technology has higher earnings, but lower revenue than Fresh Tracks Therapeutics. Creative Medical Technology is trading at a lower price-to-earnings ratio than Fresh Tracks Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Creative Medical Technology$90K61.79-$10.14M-$7.80-0.52
Fresh Tracks Therapeutics$6.94M0.78-$21.10M-$2.71-0.34

In the previous week, Fresh Tracks Therapeutics had 1 more articles in the media than Creative Medical Technology. MarketBeat recorded 1 mentions for Fresh Tracks Therapeutics and 0 mentions for Creative Medical Technology. Creative Medical Technology's average media sentiment score of 0.67 beat Fresh Tracks Therapeutics' score of 0.00 indicating that Fresh Tracks Therapeutics is being referred to more favorably in the news media.

Company Overall Sentiment
Creative Medical Technology Neutral
Fresh Tracks Therapeutics Positive

Summary

Creative Medical Technology beats Fresh Tracks Therapeutics on 9 of the 15 factors compared between the two stocks.


Get Fresh Tracks Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for FRTX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FRTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FRTX vs. The Competition

MetricFresh Tracks TherapeuticsBiological Products IndustryMedical SectorNASDAQ Exchange
Market Cap$5.43M$2.73B$4.82B$7.46B
Dividend YieldN/A2.35%5.40%3.86%
P/E Ratio-0.3410.02244.0318.27
Price / Sales0.78199.823,023.6968.34
Price / CashN/A21.2590.7154.77
Price / Book0.384.054.384.77
Net Income-$21.10M$73.80M$108.96M$205.13M
7 Day Performance-8.54%1.54%112.79%0.64%
1 Month Performance-7.14%11.45%121.55%7.69%
1 Year Performance-48.88%22.23%133.39%6.22%

Fresh Tracks Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CELZ
Creative Medical Technology
0 of 5 stars
$4.21
-0.2%
N/A-36.5%$5.81M$90,000.00-0.544High Trading Volume
TCON
TRACON Pharmaceuticals
0.9766 of 5 stars
$0.20
flat
$4.33
+2,122.2%
-89.8%$6.07M$350,000.00-0.3418Gap Down
NSTG
NanoString Technologies
3.4445 of 5 stars
$0.11
-36.3%
$7.63
+7,141.2%
N/A$5.07M$127.26M-0.03550Upcoming Earnings
Gap Down
TTNP
Titan Pharmaceuticals
0 of 5 stars
$6.52
-7.6%
N/A-57.3%$4.89M$560,000.000.004Gap Down
ALBT
Avalon GloboCare
0 of 5 stars
$0.41
flat
N/A-84.5%$4.56M$1.20M0.005
GENE
Genetic Technologies
0 of 5 stars
$1.99
-0.5%
N/A-69.2%$7.66M$5.85M0.0060Gap Up
FNCH
Finch Therapeutics Group
1.0407 of 5 stars
$2.54
-3.8%
$210.00
+8,184.0%
-77.9%$4.08M$860,000.00-0.0418Gap Down
PALI
Palisade Bio
2.0695 of 5 stars
$0.43
-4.4%
$8.75
+1,925.0%
-81.3%$4.01MN/A0.0012
EIGR
Eiger BioPharmaceuticals
4.1673 of 5 stars
$5.82
+0.2%
$120.00
+1,961.9%
-90.1%$8.61M$13.48M-0.1056Gap Down
ELOX
Eloxx Pharmaceuticals
2.1374 of 5 stars
$0.81
+5.2%
$55.00
+6,690.1%
-74.4%$2.54MN/A-0.0918Gap Up

Related Companies and Tools

This page (NASDAQ:FRTX) was last updated on 2/26/2024 by MarketBeat.com Staff